APA (7th ed.) Citation

HE, D., CB, J., DC, B., JB, L., R, Z., A, A., . . . A, G. (2023). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug safety, 46(2), 175. https://doi.org/10.1007/s40264-022-01262-4

Chicago Style (17th ed.) Citation

HE, Danysh, et al. "Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting." Drug Safety 46, no. 2 (2023): 175. https://doi.org/10.1007/s40264-022-01262-4.

MLA (9th ed.) Citation

HE, Danysh, et al. "Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting." Drug Safety, vol. 46, no. 2, 2023, p. 175, https://doi.org/10.1007/s40264-022-01262-4.